
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
Study to support differentiated efficacy of Vendaje® structural tissue allograft POMPANO BEACH, FLORIDA, October 24, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative







